Atlas Trials

Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml

Clinical trial NCT02471105 · UNKNOWN

Trial details

NCT number
NCT02471105
Sponsor
Universitaire Ziekenhuizen KU Leuven
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Ocular HypertensionGlaucoma
Start date
2015-09-01
Primary completion
2017-05-01
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.